glp-1/glucagon dual receptor agonist PDB-101: Molecule of the Month: GLP-1 Agonists Glucagon-like peptide-1 receptor: mechanisms and

doi:10.1016/j.bbrc.2017.06.031 41

Right now, the research is mixed but still growing

[DOI] [PMC free article] [PubMed] [Google Scholar] 47

Peer review Peer review information Nature Medicine thanks Kevin Wing and the other, anonymous, reviewer(s) for their contribution to the peer review of this work

Lower GLP-1 drug prices are coming, but employers still need a sustainable cost strategy The Wondr Health Team As conversations about lowering GLP1 costs continue to dominate the benefits landscape, optimism is growing

It is plausible to speculate that GLP-1 receptor agonists can induce greater weight loss than those obtained with other therapeutic interventions